{"id":23335,"date":"2024-03-20T11:13:47","date_gmt":"2024-03-20T10:13:47","guid":{"rendered":"https:\/\/ggba.swiss\/spineart-raises-chf-20-million-to-push-the-boundaries-of-spinal-surgery\/"},"modified":"2024-03-20T11:17:22","modified_gmt":"2024-03-20T10:17:22","slug":"spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/","title":{"rendered":"Spineart l\u00e8ve CHF 20 millions pour repousser les limites de la chirurgie rachidienne"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.spineart.com\/fr\/\">Spineart<\/a>, pionnier dans le domaine de la chirurgie de la colonne vert\u00e9brale, est \u00e0 la pointe de l&rsquo;innovation en mati\u00e8re de dispositifs m\u00e9dicaux depuis sa cr\u00e9ation \u00e0 Gen\u00e8ve. R\u00e9put\u00e9e pour son attention port\u00e9e \u00e0 la conception, au d\u00e9veloppement et \u00e0 la promotion de solutions s\u00fbres, efficaces et simples, Spineart r\u00e9pond aux besoins des chirurgiens de la colonne vert\u00e9brale, des \u00e9quipes des salles d&rsquo;op\u00e9ration et des patients.<\/p>\n\n\n\n<p>Le dernier tour de table a connu une participation impressionnante, avec plus de CHF 15 millions apport\u00e9s par les actionnaires existants et les employ\u00e9s. Les fonds restants ont \u00e9t\u00e9 lev\u00e9s aupr\u00e8s de nouveaux investisseurs, ce qui t\u00e9moigne d&rsquo;une confiance et d&rsquo;un soutien solides pour la vision et les technologies de pointe de Spineart. Le montant lev\u00e9 a d\u00e9pass\u00e9 l&rsquo;objectif initial de CHF 20 millions, d\u00e9montrant la forte confiance dans l&rsquo;avenir de l&rsquo;entreprise et dans ses solutions innovantes.<\/p>\n\n\n\n<p>J\u00e9r\u00f4me Trividic, CEO de Spineart, s&rsquo;est r\u00e9joui de cette lev\u00e9e de fonds : \u00ab\u00a0la cl\u00f4ture r\u00e9ussie de notre tour de financement convertible de CHF 20 millions t\u00e9moigne du potentiel de notre proth\u00e8se de disque cervical BAGUERA\u00ae C et de notre engagement in\u00e9branlable \u00e0 am\u00e9liorer la chirurgie de la colonne vert\u00e9brale gr\u00e2ce \u00e0 des technologies habilitantes et \u00e0 la navigation robotis\u00e9e.\u00a0\u00bb Ce financement va propulser Spineart vers l&rsquo;avant, permettant \u00e0 la soci\u00e9t\u00e9 d&rsquo;entreprendre plusieurs initiatives strat\u00e9giques visant \u00e0 innover davantage dans le domaine des soins de la colonne vert\u00e9brale.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Relever les d\u00e9fis des troubles d\u00e9g\u00e9n\u00e9ratifs du disque cervical<\/h4>\n\n\n\n<p>Les fonds provenant de ce tour de table seront utilis\u00e9s pour une s\u00e9rie de projets cl\u00e9s. Il s&rsquo;agit notamment d&rsquo;investissements suppl\u00e9mentaires dans de nouvelles technologies habilitantes et de la poursuite du suivi des patients qui font partie des \u00e9tudes IDE BAGUERA\u00ae C. En outre, les fonds soutiendront l&rsquo;ach\u00e8vement d&rsquo;une nouvelle usine de 4\u2019300 m\u00e8tres carr\u00e9s pr\u00e8s de Gen\u00e8ve d&rsquo;ici la fin de 2024 et l&rsquo;inauguration du nouveau centre de R&amp;D et de formation de Spineart pour les technologies habilitantes \u00e0 Dallas, au Texas.<\/p>\n\n\n\n<p>Les \u00e9tudes IDE BAGUERA\u00ae C sont essentielles pour \u00e9valuer la s\u00e9curit\u00e9 et l&rsquo;efficacit\u00e9 de la proth\u00e8se de disque cervical BAGUERA\u00ae C de Spineart, con\u00e7ue pour r\u00e9pondre aux d\u00e9fis pos\u00e9s par les troubles d\u00e9g\u00e9n\u00e9ratifs du disque cervical. La conclusion de ces \u00e9tudes est une \u00e9tape cruciale dans l&rsquo;introduction de cette technologie r\u00e9volutionnaire sur le march\u00e9 am\u00e9ricain, qui promet d&rsquo;apporter des am\u00e9liorations significatives dans les soins aux patients et les r\u00e9sultats des op\u00e9rations chirurgicales.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Spineart, le pionnier genevois des innovations en mati\u00e8re de chirurgie de la colonne vert\u00e9brale, a obtenu un financement convertible de plus de CHF 20 millions.<\/p>\n","protected":false},"author":6,"featured_media":23332,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1188,1181,1163,1142,1182],"class_list":["post-23335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-healthcare-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-rd-fr-2","tag-translational-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spineart l\u00e8ve CHF 20 millions pour la chirurgie rachidienne | GGBa<\/title>\n<meta name=\"description\" content=\"Spineart, pionnier des innovations en mati\u00e8re de chirurgie de la colonne vert\u00e9brale, a obtenu un financement de plus de CHF 20 millions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spineart l\u00e8ve CHF 20 millions pour la chirurgie rachidienne | GGBa\" \/>\n<meta property=\"og:description\" content=\"Spineart, pionnier des innovations en mati\u00e8re de chirurgie de la colonne vert\u00e9brale, a obtenu un financement de plus de CHF 20 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-20T10:13:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-20T10:17:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1-1024x704.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"704\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Spineart l\u00e8ve CHF 20 millions pour repousser les limites de la chirurgie rachidienne\",\"datePublished\":\"2024-03-20T10:13:47+00:00\",\"dateModified\":\"2024-03-20T10:17:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/\"},\"wordCount\":476,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg\",\"keywords\":[\"Healthcare\",\"Medical Devices\",\"Medtech\",\"R&amp;D\",\"Translational Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/\",\"name\":\"Spineart l\u00e8ve CHF 20 millions pour la chirurgie rachidienne | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg\",\"datePublished\":\"2024-03-20T10:13:47+00:00\",\"dateModified\":\"2024-03-20T10:17:22+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Spineart, pionnier des innovations en mati\u00e8re de chirurgie de la colonne vert\u00e9brale, a obtenu un financement de plus de CHF 20 millions.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg\",\"width\":2360,\"height\":1622,\"caption\":\"Ce financement suit de pr\u00e8s l'ach\u00e8vement des \u00e9tudes sur le disque intervert\u00e9bral BAGUERA\u00ae C (IDE) de Spineart, qui visent \u00e0 repousser les limites de la chirurgie rachidienne gr\u00e2ce \u00e0 de vastes efforts de recherche et de d\u00e9veloppement.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spineart l\u00e8ve CHF 20 millions pour repousser les limites de la chirurgie rachidienne\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spineart l\u00e8ve CHF 20 millions pour la chirurgie rachidienne | GGBa","description":"Spineart, pionnier des innovations en mati\u00e8re de chirurgie de la colonne vert\u00e9brale, a obtenu un financement de plus de CHF 20 millions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/","og_locale":"fr_FR","og_type":"article","og_title":"Spineart l\u00e8ve CHF 20 millions pour la chirurgie rachidienne | GGBa","og_description":"Spineart, pionnier des innovations en mati\u00e8re de chirurgie de la colonne vert\u00e9brale, a obtenu un financement de plus de CHF 20 millions.","og_url":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-03-20T10:13:47+00:00","article_modified_time":"2024-03-20T10:17:22+00:00","og_image":[{"width":1024,"height":704,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1-1024x704.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Spineart l\u00e8ve CHF 20 millions pour repousser les limites de la chirurgie rachidienne","datePublished":"2024-03-20T10:13:47+00:00","dateModified":"2024-03-20T10:17:22+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/"},"wordCount":476,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg","keywords":["Healthcare","Medical Devices","Medtech","R&amp;D","Translational Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/","url":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/","name":"Spineart l\u00e8ve CHF 20 millions pour la chirurgie rachidienne | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg","datePublished":"2024-03-20T10:13:47+00:00","dateModified":"2024-03-20T10:17:22+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Spineart, pionnier des innovations en mati\u00e8re de chirurgie de la colonne vert\u00e9brale, a obtenu un financement de plus de CHF 20 millions.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Spineart-Spinal-Surgery-2360x1622-1.jpeg","width":2360,"height":1622,"caption":"Ce financement suit de pr\u00e8s l'ach\u00e8vement des \u00e9tudes sur le disque intervert\u00e9bral BAGUERA\u00ae C (IDE) de Spineart, qui visent \u00e0 repousser les limites de la chirurgie rachidienne gr\u00e2ce \u00e0 de vastes efforts de recherche et de d\u00e9veloppement."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/spineart-leve-chf-20-millions-pour-repousser-les-limites-de-la-chirurgie-rachidienne\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Spineart l\u00e8ve CHF 20 millions pour repousser les limites de la chirurgie rachidienne"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=23335"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23335\/revisions"}],"predecessor-version":[{"id":23338,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23335\/revisions\/23338"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/23332"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=23335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=23335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=23335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}